# Zydus Hospira Oncology Private Ltd. – FDA Inspection, Jun 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/zydus-hospira-oncology-private-ltd/7b59ae6f-187d-47e6-b77e-fa45f958bba5
Source feed: FDA_Inspections

> FDA inspection 1209538 of Zydus Hospira Oncology Private Ltd., June 30, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209538
- Company Name: Zydus Hospira Oncology Private Ltd.
- Inspection Date: 2023-06-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1107385 - 2019-10-22](https://www.keypedia.com/records/fda_inspections/zydus-hospira-oncology-private-ltd/45367c8e-d0a9-4d85-98cc-02abfd4cebe6)
- [FDA Inspection 1048779 - 2018-04-12](https://www.keypedia.com/records/fda_inspections/zydus-hospira-oncology-private-ltd/5353f90a-015e-4e40-905f-ca883f90d753)
- FDA Inspection 899318 - 2014-09-16
- FDA Inspection 794202 - 2012-07-26

## Related Officers

- Rodney G. Raiford
- [Wayne D. Mcgrath](https://www.keypedia.com/people/wayne-d-mcgrath/42db5ab0-2e0b-4909-951c-e7621cd04f6e)

Company: https://www.keypedia.com/companies/zydus-hospira-oncology-private-ltd/1daf2047-24d1-4343-9500-8a3c69eccaf4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c